Effects of endomorphin-1 postconditioning on myocardial ischemia/reperfusion injury and myocardial cell apoptosis in a rat model

  • Authors:
    • Wei‑Ping Zhang
    • Qiao‑Feng Zong
    • Qin Gao
    • Ying Yu
    • Xiao‑Yu Gu
    • Ya Wang
    • Zheng‑Hong Li
    • Min Ge
  • View Affiliations

  • Published online on: August 31, 2016     https://doi.org/10.3892/mmr.2016.5695
  • Pages: 3992-3998
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Endomorphins (EMs) have important roles in the body with regards to analgesia, feeding behavior, gastrointestinal movement and inflammatory reaction. Recent studies have reported that EMs may also participate in chronic hypoxia in the protection of rat myocardial ischemia/reperfusion; however, the mediator and underlying mechanisms remain to be elucidated. The aim of the present study was to investigate the effects of EM‑1 postconditioning on myocardial ischemia/reperfusion injury (MIRI) and myocardial cell apoptosis in a rat model, and to assess its likely mechanisms. A total of 48 male Sprague Dawley rats were randomly divided into four groups: Sham group, ischemia/reperfusion group (IR group), ischemic postconditioning group (IPO group) and EM‑1 postconditioning group (EM50 group). A MIRI model was established via occlusion of the left anterior descending branch of the coronary artery for 30 min, followed by reperfusion for 120 min in vivo. Hemodynamic indexes were recorded and analyzed. Following reperfusion, plasma lactate dehydrogenase (LDH), creatine kinase‑MB (CK‑MB), malondialdehyde (MDA), superoxide dismutase (SOD), interleukin‑6 (IL‑6) and tumor necrosis factor‑α (TNF‑α) contents or activities were measured, infarct size was determined, and the expression levels of B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) mRNA and cleaved caspase‑3 protein were assessed. In the IR group, mean arterial pressure (MAP) and heart rate (HR) were decreased compared with in the sham group. In addition, LDH and CK‑MB levels were increased; IL‑6, TNF‑α and MDA content was increased; SOD activity was decreased; the Bcl‑2/Bax ratio was decreased; and cleaved caspase‑3 protein expression levels were increased in the IR group. Compared with in the IR group, in the IPO and EM50 groups, MAP and heart rate (HR) were recovered to various extents post‑reperfusion; LDH and CK‑MB levels were decreased; IL‑6, TNF‑α and MDA content was decreased; SOD activity was increased; infarct size was reduced; the Bcl‑2/Bax ratio was increased; and cleaved caspase‑3 protein expression levels were decreased. In conclusion, EM‑1 postconditioning was revealed to reduce I/R injury and inhibit myocardial cell apoptosis, which may be associated with reductions in oxidative stress and inflammatory reactions.

Introduction

Endomorphins (EMs) are a type of opioid peptide, which were initially identified in 1997 by Zadina et al (1); their identification prompted research into endogenous opioid peptides. EMs have important roles in the body with regards to analgesia (2), feeding behavior (3), gastrointestinal movement (4) and inflammation (5). In recent years, EMs have been reported to have an important role in cardiovascular biology (6), and have been shown to protect endothelial cells by slowing down the process of apoptosis and promoting proliferation under physiological concentrations (7,8).

In recent years, the incidence of acute myocardial infarction has increased, and myocardial ischemia/reperfusion injury (MIRI) is considered a complex problem. Due to the time limit of ischemic preconditioning (IPC) and the invasive operation associated with ischemic postconditioning (IPO), pharmacological postconditioning (9) is considered a more feasible measure to reduce MIRI. Previous studies have suggested that exogenous opioids, including morphine, fentanyl and remifentanil, can resist MIRI and exert myocardial protection; however, the long-standing or excessive use of exogenous drugs may produce toxicity to the organism (10,11). Therefore, the use of EMs, which are endogenous opioids, may be considered a promising novel therapeutic strategy. Numerous studies have confirmed that MIRI can induce oxidative stress, mitochondrial dysfunction and inflammation (12,13). Furthermore, previous studies have reported that EMs have an important role in clearing oxygen free radicals (14) and inhibiting mitochondrial dysfunction (15). It has also been demonstrated that EMs may participate in chronic hypoxia in the protection of rat MIRI (16). There are two types of EM: EM-1 and EM-2. EM-1 is widely distributed in the brain (17) and may have a certain correlation with cardiovascular regulatory function.

Cell apoptosis has a substantial role in MIRI; it is an important process in the occurrence and development of MIRI (18), and a relevant mechanism underlying myocardial damage and myocardial cell loss (1921). Therefore, the present study aimed to determine the effects of EM-1 postconditioning on MIRI and myocardial cell apoptosis in a rat model, and to analyze the underlying mechanisms.

Materials and methods

Animals

Male clean-grade Sprague Dawley rats (weight, 250–350 g; age, 3 months) were obtained from the Animal Center of Bengbu Medical College (Bengbu, China). The rats were fed a normal diet and had ad libitum access to water. All rats were housed in cages at 25±1°C with a fixed 12-h light/dark cycle. All animal procedures were conducted in accordance with the United States National Institutes of Health Guide, and were approved by the Animal Use and Care Committee of Bengbu Medical College.

Materials and primary reagents

EM-1 was purchased from Sigma-Aldrich (Merck Millipore, Darmstadt, Germany). Lactate dehydrogenase (LDH), malondialdehyde (MDA) and superoxide dismutase (SOD) assay kits were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The creatine kinase MB (CK-MB) isoenzyme enzyme-linked immunosorbent assay (ELISA) kit, interleukin-6 (IL-6) ELISA kit and tumor necrosis factor-α (TNF-α) ELISA kit were purchased from Biocalvin Co., Ltd. (Jiangsu, China). cDNA (#K1622) and polymerase chain reaction (PCR) kits were purchased from Fermentas (Thermo Fisher Scientific, Inc., Waltham, MA, USA (#K0171). B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax) and β-actin primers were synthesized by Sangon Biotech Co., Ltd. (Shanghai China). Mouse β-actin antibody was purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA).

Experimental method
MIRI rat model generation in vivo

All rats were fasted for 12 h and were given ad libitum access to water prior to the trial. The rats were injected with 4% chloral hydrate (1 ml/100 g) intra-peritoneally prior to the operation. Anaesthetized rats were fixed on the operating table in a supine position. A tracheal cannula was inserted into the rats, which was connected to a breathing machine (tidal volume, 2–3 ml/100 g; respiratory rate, 70–80 times/min). The right carotid artery of each rat was separated and an arterial cannula was inserted, which was connected to the Med-Lab system (Nanjing Medease Science and Technology Co., Ltd., Nanjing China), in order to record changes to heart rate (HR) and mean arterial pressure (MAP). The chest of each rat was sheared and an incision was made along the left sternal border, separating the pericardium and exposing the heart. Subsequently, 5–0 fine silk was threaded through the bottom of the left anterior descending coronary artery (LAD). Following LAD ligation, ST-T elevation shown in the electrocardiogram indicated the success of ischemia. The LAD was ligated for 30 min (ischemia) followed by 120 min reperfusion in vivo, following 20 min stabilization. The MIRI model was thus accomplished (22).

Animal experimental groups

Male Sprague Dawley rats (n=48) were randomly divided into four groups (n=12/group): Sham group, ischemia/reperfusion group (IR), IPO group and EM-1 postconditioning (50 μg/kg) group (EM50). The groups underwent the following procedures: i) Sham group, LAD ligation with no other intervention for 150 min; ii) IR group: LAD was ligated for 30 min (ischemia), and was reperfused for l20 min in vivo; iii) IPO group, after 30 min ischemia, three cycles of LAD clamping for 15 sec and declamping for 15 sec were performed prior to reperfusion; iv) EM50 group: EM-1 (50 μg/kg) was administered intravenously following LAD ligation for 25 min, subsequently the LAD was reperfused for l20 min in vivo.

Determination of hemodynamic characteristics

MAP and HR were continuously monitored and recorded using the Med-Lab hemodynamic system throughout the whole process of the experiment. Rate pressure product (RPP) was calculated using the following equation: RPP = MAP × HR.

Plasma IL-6, TNF-α and MDA content, and LDH, CK-MB and SOD activity

Following reperfusion, arterial blood samples were collected and placed in heparinized centrifuge tubes, and were centrifuged at 1,509 × g for 20 min at 4°C. The supernatant was collected and stored at −80°C. MDA content, and LDH and SOD activities were measured using colorimetric assays. IL-6 and TNF-α content, and CK-MB activity were measured by enzyme-linked immunosorbent assay using commercially available kits according to the manufacturers' protocols.

Determination of myocardial infarct size

The rats were injected with 4% chloral hydrate (1 ml/100 g) intraperitoneally and sacrificed by beheading prior to heart removal. The heart was removed alongside the LAD at the end of reperfusion, and 1% Evans blue was injected into the heart through the aorta. The heart was subsequently cut into 2 mm sections vertical to the longitudinal axis after freezing, and the sections were dyed with 1% triphenyl tetrazolium chloride in a 37°C water bath for 10–15 min. Subsequently, the sections were fixed in 10% formalin buffer and were divided into various regions according to color; the blue zone is considered the non-infarcted zone, the red zone is the area at risk (AAR), and the white zone is used to determine infarct size (IS). The relative area was measured using Image-Pro Plus software 6.0 (Media Cybernetics, Inc., Rockford, MD, USA) following image acquisition. The myocardial IS was expressed as a percentage of the AAR.

Detection of Bcl-2 and Bax mRNA levels by reverse transcription (RT)-PCR

Following the operation, left anterior myocardial tissues (0.1 g) were collected from each group and homogenized, and total RNA was extracted using TRIzol® (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. Total RNA (2 μg) was reverse transcribed to cDNA in a 25 μl PCR reaction volume, containing 1 μl forward primer, 1 μl reverse primer, 9 μl nuclease-free water, 12.5 μl PCR Master mix and 1.5 μl cDNA (all reagents were obtained from Fermentas; Thermo Fisher Scientific, Inc.) Subsequently RNA concentration was detected, and RT and PCR amplification were conducted. The primer sequences are shown in Table I. The PCR cycling conditions were as follows: Initial denaturation at 95°C for 3 min; followed by 30 cycles of denaturation at 95°C for 50 sec, annealing at 59.4°C (β-actin), 64.5°C (Bax), 61.5°C (Bcl-2) for 50 sec, and extension at 72°C for 60 sec; and final extension at 72°C for 10 min; PCR products were then maintained at 4°C. The PCR products were analyzed by 1% agarose gel electrophoresis and were stained with ethidium bromide. The densitometric results for Bcl-2 and Bax were compared with corresponding β-actin levels to account for loading differences. Tanon Dots 3. 1. 2 software (Tanon Science & Technology Co., Ltd., Shanghai, China) was used for analysis.

Table I

Polymerase chain reaction primers for Bax, Bcl-2 and β-actin.

Table I

Polymerase chain reaction primers for Bax, Bcl-2 and β-actin.

GenePrimerSequenceProduct (bp)
BaxForward5′-GGA TCG AGC AGA GAG GAT GG-3′464
Reverse5′-TGG TGA GTG AGG CAG TGA GG-3′
Bcl-2Forward5′-CTG GTG GAC AAC ATC GCT CTG-3′228
Reverse5′-GGT CTG CTG ACC TCA CTT GTG-3′
β-actinForward5′-GAT GGT GGG TAT GGG TCA GAA GGA C-3′632
Reverse5′-GCT CAT TGC CGA TAG TGA TGA CT-3′

[i] Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein.

Detection of cleaved caspase-3 protein by western blotting

Following the operation, rat ventricular tissues (0.1 g) were collected from each group and were homogenized in 1 ml protein extraction buffer (10 μl phenylmethylsulfonyl fluoride, 990 μl lysis buffer). The supernatant was collected following centrifugation (12,000 x g for 30 min at 4°C) and protein content was determined using the bicinchoninic acid method. The quantity of the total protein samples was 20 μg, which was diluted in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer. Following denaturation, the samples were separated by 12% SDS-PAGE and were transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% skimmed milk at 37°C for 120 min. The membranes were then incubated at 4°C overnight with rabbit cleaved caspase-3 antibody (1:1,000 cat. no. #9664) and mouse β-actin antibody (1:500; cat. no. #BM0627). Subsequently, membranes were incubated for 60 min at 37°C with horseradish peroxidase (HRP)-conjugated anti-mouse immunoglobulin (Ig)G (1:10,000; cat. no. #BA1050)) or HRP-conjugated anti-rabbit IgG (1:10,000; cat. no. #BA1054) secondary antibodies. The membranes were visualized using a chemiluminescent HRP substrate. The band densities were determined and analyzed with a automatic digital gel image analysis system Tanon 3500 (Tanon Science & Technology Co., Ltd., Shanghai, China).

Statistical analysis

Data are presented as the mean ± standard deviation (n=12). One-way analysis of variance followed by least significance difference test was used for multiple comparisons. All data were analyzed using GraphPad Prism version 4.0 software (GraphPad Software, Inc., San Diego, CA, USA). P<0.05 was considered to indicate a statistically significant difference.

Results

Alterations to hemodynamic characteristics

Basal HR, MAP and RPP were not identified to be significantly different between the groups at baseline (P>0.05). During the period of ischemia, HR, MAP and RPP were significantly decreased in the IR group (P<0.01) compared with in the sham group. Compared with in the IR group, HR, MAP and RPP were increased in the IPO and EM50 groups (P<0.05, P<0.01). During the period of reperfusion, HR, MAP and RPP were significantly decreased in the IR group (P<0.01) compared with the sham group. Compared with in the IR group, HR, MAP and RPP were increased in the IPO and EM50 groups (P<0.05, P<0.01) (Table II).

Table II

Hemodynamic characteristics of the rats in each group.

Table II

Hemodynamic characteristics of the rats in each group.

VariableBaselineIschemia 30 minReperfusion
30 min60 min120 min
HR (beats/min)
 Sham399.33±23.77394.50±24.44396.83±23.46383.83±21.15367.50±28.66
 IR390.50±20.42 273.83±49.14a 299.47±48.19a 281.26±44.60a 284.01±34.99a
 IPO412.84±28.11 320.63±25.77a,b 345.82±25.48b,c 340.60±38.48d 341.14±20.44d
 EM50404.55±11.26 347.20±22.27b,d 364.23±22.76d 352.16±14.46d 339.94±26.65d
MAP (mmHg)
 Sham106.14±7.2399.67±7.9194.00±6.4092.56±7.1992.67±6.89
 IR117.51±10.6255.89±21.63a70.85±18.04a66.38±15.30a55.83±20.98a
 IPO115.29±7.6877.08±9.65b,c88.77±7.99b84.70±10.19b80.10±22.31b
 EM50110.98±13.2493.98±22.79d93.36±12.41d85.52±10.72b75.02±14.45
RPP (mmHg/min/10−3)
 Sham42.52±5.3039.42±5.0637.39±4.3035.60±4.2034.10±4.15
 IR45.80±3.6315.79±7.93a20.77±4.74a18.73±5.64a16.18±7.00a
 IPO47.61±4.8324.88±5.02a,b30.83±4.89d28.72±3.88d27.22±7.09d
 EM5044.99±6.2232.90±9.37d34.20±6.42d30.22±4.87b25.66±6.13b,c

{ label (or @symbol) needed for fn[@id='tfn2-mmr-14-04-3992'] } Data are presented as the mean ± standard deviation.

a P<0.01 vs. Sham group;

b P<0.05 vs. IR group,

c P<0.05 vs. Sham group,

d P<0.01 vs. IR group. Sham, left anterior descending coronary artery ligation with no other intervention; IR, ischemia/reperfusion; IPO, ischemic postconditioning; EM50, endomorphin-1 (50 μg/kg) postconditioning; MAP, mean arterial pressure; HR, heart rate; RPP, rate pressure product.

Alterations in LDH and CK-MB plasma activities

In the IR, IPO and EM50 groups, LDH and CK-MB activities were significantly higher compared with in the sham group (P<0.01). Compared with in the IR group, LDH and CK-MB activities were significantly decreased in the IPO and EM50 groups (Fig. 1; P<0.01).

Alterations in MDA content and SOD activity in the plasma

Compared with Sham group, in IR, IPO, and EM50 groups, SOD activity was significantly reduced and MDA content was increased. Compared with in the IR group, SOD activity was significantly increased and MDA content was significantly decreased in the IPO and EM50 groups (Fig. 2; P<0.01).

Alterations in IL-6 and TNF-α plasma content

In the IR group, IL-6 and TNF-α levels were significantly increased compared with in the sham group (P<0.01). Compared with in the IR group, IL-6 and TNF-α levels were significantly decreased in the IPO and EM50 groups (P<0.01; Fig. 3).

Alterations to myocardial infarct size in rats

Myocardial infarct size (% IS/AAR) was significantly decreased in the IPO and EM50 groups (P<0.01) compared with in the IR group (Fig. 4).

Alterations in the mRNA expression levels of myocardial Bcl-2 and Bax

The results of the RT-PCR revealed that, compared with the sham group, the mRNA expression levels of Bcl-2 and the ratio of Bcl-2/Bax were significantly reduced (P<0.01), whereas the expression levels of Bax were significantly increased (P<0.01) in the IR group. Compared with in the IR group, the mRNA expression levels of Bcl-2 and the ratio of Bcl-2/Bax were significantly increased (P<0.01), whereas the mRNA expression levels of Bax were significantly reduced (P<0.01) in the IPO and EM50 groups (Fig. 5).

Alterations in the protein expression levels of cleaved caspase-3

The protein expression levels of cleaved caspase-3 were higher in the IR, IPO and EM50 groups compared with in the sham group (P<0.05, P<0.01). Compared with in the IR group, the ratio of cleaved caspase-3/β-actin was significantly reduced in the IPO and EM50 groups (P<0.01; Fig. 6).

Discussion

The myocardial restoration of blood flow following ischemia may induce significant pathological and physiological reperfusion-associated alterations to myocardial cells and the local vascular network, further aggravating myocardial damage; this process is known as MIRI. In the present study, a successful rat model of MIRI was generated in vivo. Hemodynamic indexes, myocardial enzymes and myocardial infarct size all reflect the degree of I/R damage. Previous studies have demonstrated that the primary mechanisms underlying MIRI may include excessive production of free radicals, infiltration of inflammatory cells, mitochondrial dysfunction and apoptosis of myocardial cells (19,2325). Therefore, reducing the generation of free radicals (26), inhibiting the inflammatory response and suppressing apoptosis (27) may markedly reduce I/R injury.

The myocardial restoration of blood flow following ischemia may produce a large number of free radicals, which can cause oxidative stress, lipid peroxidation and lead to further injury of the myocardial tissue. SOD is one of the most important radical scavenging enzymes, whereas MDA is a metabolite of lipid peroxidation; therefore, measuring plasma SOD activity and MDA content can reflect the production of oxygen free radicals and the degree of myocardial cell damage (28). The results of the present study indicated that SOD activity was increased and MDA content was reduced in the plasma from IPO and EM50 groups compared with in the IR group. These results suggested that EM-1 postconditioning may alleviate MIRI by reducing the production of free radicals.

Inflammation is an important mechanism that is closely associated with the occurrence and development of MIRI (29). MIRI is characterized by a local or systemic inflammatory response, the development of which is complex. TNF-α is a cytokine that is predominantly produced by macrophages, which is involved in the formation and development of MIRI. It has previously been reported that excessive activation of TNF-α can significantly damage myocardial function and prompt myocardial cell apoptosis, thus increasing myocardial damage (30). IL-6 is considered a marker of inflammation, which is responsible for inflammatory regulation and is also closely associated with the occurrence and development of MIRI (31). The present study indicated that in the IPO and EM50 groups the plasma levels of IL-6 and TNF-α were reduced compared with in the IR group. These findings suggested that EM-1 postconditioning may alleviate MIRI by inhibiting the inflammatory response.

Cell apoptosis is the primary mechanism underlying MIRI. Cell apoptosis is controlled by several genes and enzymatic reactions, the molecular regulatory mechanism of which is complex. The Bcl-2 family has an important role in cell apoptosis, and the Bcl-2 gene is the most representative anti-apoptotic gene of the Bcl-2 family. The Bax gene shares 21% amino acid sequence homology with the Bcl-2 gene, and is able to suppress the anti-apoptotic function of Bcl-2; the Bcl-2/Bax ratio (32,33) determines the occurrence of cell apoptosis. The cysteine aspartic acid specific protease, or caspase, family also has an important role in mediating apoptosis. Caspase-3 is an important caspase family enzyme that induces the execution of apoptosis, and is involved in the process of cell apoptosis after activation by enzyme digestion. In addition, caspase-3 is an important proteinase of the caspase enzyme cascade reaction; therefore, caspase-3 is considered an enzymatic marker of apoptosis. The present study demonstrated that in the IPO and EM50 groups the Bcl-2/Bax ratio was increased, whereas the protein expression levels of cleaved caspase-3 were reduced compared with the IR group; therefore, EM-1 postconditioning may produce anti-apoptotic effects in MIRI.

There are several mechanisms underlying MIRI and their relationship is complex. Causal relationships may exist between the mechanisms, and they may interact with each other leading to myocardial injury. The number of neutrophils is markedly increased during reperfusion, and neutrophils produce an excess of oxygen free radicals, which can in turn induce oxidative stress, lipid peroxidation and inflammation, thus promoting cell apoptosis leading to further injury of myocardial tissue. It has previously been reported that the production of oxygen free radicals, accumulation of neutrophils and complement activation may be associated with the inflammatory response (34). Furthermore, the excessive activation of TNF-α can prompt myocardial cell apoptosis and increase myocardial damage (30). The present study demonstrated that EMs may produce anti-apoptotic effects by resisting oxidative stress, lipid peroxidation and inhibiting the inflammatory response; it may be hypothesized that EMs also produce an anti-apoptotic effect via certain signaling pathways, such as the phopshoinositide 3-kinase/Akt and extracellular signal-regulated kinases /2 signaling pathways; the related mechanisms require further study.

In conclusion, the present study demonstrated that EM-1 postconditioning may exert myocardial protection and anti-apoptotic effects by resisting oxidative stress, lipid peroxidation and inhibiting the inflammatory response. Although EMs only have four amino acid residues, they contain abundant information. Therefore, in the future, EMs may have broad application prospects, not only in analgesia, but also in the treatment of cardiovascular conditions.

Acknowledgments

The present study was supported by research grants from the Chinese National Natural Science Foundation (grant no. 81472656) and the Anhui Province Natural Science Foundation (grant no. 1508085MH170).

References

1 

Zadina JE, Hackler L, Ge LJ and Kastin AJ: A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 386:499–502. 1997. View Article : Google Scholar : PubMed/NCBI

2 

Mizoguchi H, Takagi H, Watanabe C, Yonezawa A, Sato T, Sakurada T and Sakurada S: Involvement of multiple μ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission. Peptides. 51:15–25. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Brunetti L, Ferrante C, Orlando G, Recinella L, Leone S, Chiavaroli A, Di Nisio C, Shohreh R, Manippa F, Ricciuti A, et al: Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus. Peptides. 48:83–88. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Wang CL, Zhou Y, Guo C, Zhang Y and Wang R: In vivo characterization of intestinal effects of endomorphin-1 and endomorphin-2 in type 1 diabetic mice. Eur J Pharmacol. 698:499–504. 2013. View Article : Google Scholar

5 

Block L, Björklund U, Westerlund A, Jörneberg P, Biber B and Hansson E: A new concept affecting restoration of inflammation-reactive astrocytes. Neuroscience. 250:536–545. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Chen ZC, Shieh JP, Chung HH, Hung CH, Lin HJ and Cheng JT: Activation of peripheral opioid μ-receptors in blood vessel may lower blood pressure in spontaneously hypertensive rats. Pharmacology. 87:257–264. 2011. View Article : Google Scholar

7 

Dai X, Song HJ, Cui SG, Wang T, Liu Q and Wang R: The stimulative effects of endogenous opioids on endothelial cell proliferation, migration and angiogenesis in vitro. Eur J Pharmacol. 628:42–50. 2010. View Article : Google Scholar

8 

Liu J, Wei S, Tian L, Yan L, Guo Q and Ma X: Effects of endo-morphins on human umbilical vein endothelial cells under high glucose. Peptides. 32:86–92. 2011. View Article : Google Scholar

9 

Burley DS and Baxter GF: Pharmacological targets revealed by myocardial postconditioning. Curr Opin Pharmacol. 9:177–188. 2009. View Article : Google Scholar

10 

Tanaka K, Kersten JR and Riess ML: Opioid-induced cardioprotection. Curr Pharm Des. 20:5696–5705. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Li R, Wong GT, Wong TM, Zhang Y, Xia Z and Irwin MG: Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats. Anesth Analg. 108:23–29. 2009. View Article : Google Scholar

12 

Brown DA, Sabbah HN and Shaikh SR: Mitochondrial inner membrane lipids and proteins as targets for decreasing cardiac ischemia/reperfusion injury. Pharmacol Ther. 140:258–266. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Neri M, Fineschi V, Di Paolo M, Pomara C, Riezzo I, Turillazzi E and Cerretani D: Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr Vasc Pharmacol. 13:26–36. 2015. View Article : Google Scholar

14 

Gong P, Chen FX, Zhao Q, Ma GF and Wang R: The oxidation metabolites of endomorphin 1 and its fragments induced by free radicals. J Pept Sci. 15:337–344. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Feng Y, Lu Y, Lin X, Gao Y, Zhao Q, Li W and Wang R: Endomorphins and morphine limit anoxia-reoxygenation-induced brain mitochondrial dysfunction in the mouse. Life Sci. 82:752–763. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Maslov LN, Naryzhnaia NV, Tsibulnikov SY, Kolar F, Zhang Y, Wang H, Gusakova AM and Lishmanov YB: Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia. Life Sci. 93:373–379. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Martin-Schild S, Gerall AA, Kastin AJ and Zadina JE: Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol. 405:450–471. 1999. View Article : Google Scholar : PubMed/NCBI

18 

Singh SS and Kang PM: Mechanisms and inhibitors of apoptosis in cardiovascular diseases. Curr Pharm Des. 17:1783–1793. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Savateev AV and Savateeva-Liubimova TN: Apoptosis-universal mechanisms of cell death and survival in ischemia and reperfusion: Ways to pharmacological control. Eksp Klin Farmakol. 73:44–49. 2010.In Russian.

20 

Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, Lips DJ and Doevendans PA: Role of apoptosis in reperfusion injury. Cardiovasc Res. 61:414–426. 2004. View Article : Google Scholar : PubMed/NCBI

21 

Yu-hui H, Yun F, Fen J and Xing L: Study about cardiomyocyte apoptosis in myocardial ischemic-reperfusion injury of rats and NF-κB p65, iNOS expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 26:868–870. 2010.In Chinese. PubMed/NCBI

22 

Zhou H, Hou SZ, Luo P, Zeng B, Wang JR, Wong YF, Jiang ZH and Liu L: Ginseng protects rodent hearts from acute myocardial ischemia reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism. J Ethnopharmacol. 135:287–298. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Mozaffari MS, Liu JY, Abebe W and Baban B: Mechanisms of load dependency of myocardial ischemia reperfusion injury. Am J Cardiovasc Dis. 3:180–196. 2013.PubMed/NCBI

24 

Saleem MT, Chetty MC and Kavimani S: Putative antioxidant property of sesame oil in an oxidative stress model of myocardial injury. J Cardiovasc Dis Res. 4:177–181. 2013. View Article : Google Scholar :

25 

Gottlieb RA: Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther. 16:233–238. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Kurian GA, Suryanarayanan S, Raman A and Padikkala J: Antioxidant effects of ethyl acetate extract of Desmodium gangeticum root on myocardial ischemia reperfusion injury in rat hearts. Chin Med. 5:32010. View Article : Google Scholar : PubMed/NCBI

27 

Yi X, Cui X, Wu P, Wang S, Wang G, Yang X, Yang F, Zheng S and Li Z: Effects of N-acetylcysteine on apoptosis induced by myocardial ischemia reperfusion injury in rats' heart transplantation. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 27:1234–1239. 2013.In Chinese.

28 

Gao YH, Chen L, Ma YL and He QY: Chronic intermittent hypoxia aggravates cardiomyocyte apoptosis in rat ovariectomized model. Chin Med J (Engl). 125:3087–3092. 2012.

29 

Wang Y, Zhang ZZ, Wu Y, Zhan J, He XH and Wang YL: Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation. Exp Ther Med. 5:315–319. 2013.

30 

Su H, Yuan Y, Wang XM, Lau WB, Wang Y, Wang X, Gao E, Koch WJ and Ma XL: Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNFα-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice. Basic Res Cardiol. 108:3152013. View Article : Google Scholar

31 

Wang Q, Cheng Y, Xue FS, Yuan YJ, Xiong J, Li RP, Liao X and Liu JH: Postconditioning with vagal stimulation attenuates local and systemic inflammatory responses to myocardial ischemia reperfusion injury in rats. Inflamm Res. 61:1273–1282. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Jin S and Dai CL: Attenuation of reperfusion-induced hepatocyte apoptosis is associated with reversed bcl-2/bax ratio in hemi-hepatic artery-preserved portal occlusion. J Surg Res. 174:298–304. 2012. View Article : Google Scholar

33 

Yao Y, Huang C, Li ZF, Wang AY, Liu LY, Zhao XG, Luo Y, Ni L, Zhang WG and Song TS: Exogenous phosphatidylethanolamine induces apoptosis of human hepatoma HepG2 cells via the bcl-2/Bax pathway. World J Gastroenterol. 15:1751–1758. 2009. View Article : Google Scholar : PubMed/NCBI

34 

Seelinger G, Merfort I and Schempp CM: Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 74:1667–1677. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October-2016
Volume 14 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang WP, Zong QF, Gao Q, Yu Y, Gu XY, Wang Y, Li ZH and Ge M: Effects of endomorphin-1 postconditioning on myocardial ischemia/reperfusion injury and myocardial cell apoptosis in a rat model. Mol Med Rep 14: 3992-3998, 2016
APA
Zhang, W., Zong, Q., Gao, Q., Yu, Y., Gu, X., Wang, Y. ... Ge, M. (2016). Effects of endomorphin-1 postconditioning on myocardial ischemia/reperfusion injury and myocardial cell apoptosis in a rat model. Molecular Medicine Reports, 14, 3992-3998. https://doi.org/10.3892/mmr.2016.5695
MLA
Zhang, W., Zong, Q., Gao, Q., Yu, Y., Gu, X., Wang, Y., Li, Z., Ge, M."Effects of endomorphin-1 postconditioning on myocardial ischemia/reperfusion injury and myocardial cell apoptosis in a rat model". Molecular Medicine Reports 14.4 (2016): 3992-3998.
Chicago
Zhang, W., Zong, Q., Gao, Q., Yu, Y., Gu, X., Wang, Y., Li, Z., Ge, M."Effects of endomorphin-1 postconditioning on myocardial ischemia/reperfusion injury and myocardial cell apoptosis in a rat model". Molecular Medicine Reports 14, no. 4 (2016): 3992-3998. https://doi.org/10.3892/mmr.2016.5695